A clinical formulation indicated for Eye Care. Regular use supports the lowering of fluid pressure within the eyes and aids in protecting long-term vision pathways.
Designed to manage intraocular pressure by addressing multiple fluid production pathways to alleviate optic nerve strain and support vision preservation in glaucoma patients.
Mechanism of Action
Dorzolamide reduces fluid secretion in the eye by blocking a specific enzyme. Timolol, a beta-blocker, also reduces fluid production and slightly improves drainage. Together, they provide superior pressure reduction compared to using either alone.
Route of Administration
Ophthalmic
Onset Time
2 hours
Duration
12 hours
Contraindications
Asthma, Severe COPD, Sinus bradycardia, Severe renal failure, Hypersensitivity to components
Information for Cosopt is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
